Bharat Biotech Commits 500 Million Doses Of Covaxin To Centre
Bharat Biotech’s Covaxin demonstrated 77.8% effectiveness against symptomatic COVID-19 and 65.2% protection against the B.1.617.2 Delta variant, Bharat Biotech said…
Bharat Biotech’s Covaxin demonstrated 77.8% effectiveness against symptomatic COVID-19 and 65.2% protection against the B.1.617.2 Delta variant, Bharat Biotech said…
Crown Prosecution Service barrister Helen Malcolm argued against permission to appeal by reiterating that the expert evidence on Nirav’s mental health has…